🇺🇸 FDA
Pipeline program

Xiang-Sha-Liu-Jun-Zi-Tang

CMUH103-REC2-016

Phase 3 small_molecule active

Quick answer

Xiang-Sha-Liu-Jun-Zi-Tang for Irritable Bowel Syndrome is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Irritable Bowel Syndrome
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials